Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2010 | 1 |
2012 | 1 |
2014 | 1 |
2015 | 1 |
2018 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
First-Line Venetoclax Combinations in Chronic Lymphocytic Leukemia.
N Engl J Med. 2023 May 11;388(19):1739-1754. doi: 10.1056/NEJMoa2213093.
N Engl J Med. 2023.
PMID: 37163621
Clinical Trial.
Efficacy and safety of irinotecan-based chemotherapy for advanced colorectal cancer outside clinical trials: an observational study.
Moehler M, Ababneh Y, Verpoort K, Schmidt B, Musch R, Soeling U, Maintz C, Siebler J, Schimanski CC, Galle PR, Fahlke J.
Moehler M, et al. Among authors: soeling u.
Onkologie. 2010;33(12):684-90. doi: 10.1159/000322208. Epub 2010 Nov 22.
Onkologie. 2010.
PMID: 21124039
Clinical Trial.
Item in Clipboard
Endocrine Treatment with 2 Years of Tamoxifen versus 2 Years of Exemestane in Postmenopausal Patients with High-Risk Early Breast Cancer and Persisting Circulating Tumor Cells - First Results of the SUCCESS C Endocrine Treatment Sub-Study.
Schochter F, Rack B, Tzschaschel M, Polasik A, Andergassen U, Trapp E, Alunni-Fabbroni M, Schneeweiss A, Müller V, Pantel K, Gade J, Lorenz R, Rezai M, Tesch H, Soeling U, Fehm T, Mahner S, Schindlbeck C, Lichtenegger W, Beckmann MW, Fasching PA, Janni W, Friedl TWP; SUCCESS Study Group.
Schochter F, et al. Among authors: soeling u.
Oncol Res Treat. 2018;41(3):93-98. doi: 10.1159/000485566. Epub 2018 Feb 27.
Oncol Res Treat. 2018.
PMID: 29490302
Clinical Trial.
Item in Clipboard
Quality of life under capecitabine (Xeloda®) in patients with metastatic breast cancer: data from a german non-interventional surveillance study.
Müller V, Fuxius S, Steffens CC, Lerchenmüller C, Luhn B, Vehling-Kaiser U, Hurst U, Hahn LJ, Soeling U, Wohlfarth T, Zaiss M.
Müller V, et al. Among authors: soeling u.
Oncol Res Treat. 2014;37(12):748-55. doi: 10.1159/000369487. Epub 2014 Nov 21.
Oncol Res Treat. 2014.
PMID: 25531721
Free article.
Item in Clipboard
Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.
Rödel C, Graeven U, Fietkau R, Hohenberger W, Hothorn T, Arnold D, Hofheinz RD, Ghadimi M, Wolff HA, Lang-Welzenbach M, Raab HR, Wittekind C, Ströbel P, Staib L, Wilhelm M, Grabenbauer GG, Hoffmanns H, Lindemann F, Schlenska-Lange A, Folprecht G, Sauer R, Liersch T; German Rectal Cancer Study Group.
Rödel C, et al.
Lancet Oncol. 2015 Aug;16(8):979-89. doi: 10.1016/S1470-2045(15)00159-X. Epub 2015 Jul 15.
Lancet Oncol. 2015.
PMID: 26189067
Clinical Trial.
Item in Clipboard
Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial.
Rödel C, Liersch T, Becker H, Fietkau R, Hohenberger W, Hothorn T, Graeven U, Arnold D, Lang-Welzenbach M, Raab HR, Sülberg H, Wittekind C, Potapov S, Staib L, Hess C, Weigang-Köhler K, Grabenbauer GG, Hoffmanns H, Lindemann F, Schlenska-Lange A, Folprecht G, Sauer R; German Rectal Cancer Study Group.
Rödel C, et al.
Lancet Oncol. 2012 Jul;13(7):679-87. doi: 10.1016/S1470-2045(12)70187-0. Epub 2012 May 23.
Lancet Oncol. 2012.
PMID: 22627104
Clinical Trial.
Item in Clipboard
Cite
Cite